WEIFANG, SHANDONG, CHINA, January 21, 2026 /EINPresswire.com/ -- Introduction: A Global Innovator from Shandong, China ...
Fractyl Health announced a first-in-human trial for RJVA-001, targeting T2D and obesity, pending regulatory approval by 2026. Fractyl Health, Inc. has announced the submission of the first module of ...
A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the ...
The transformative impact of artificial intelligence (AI) on clinical research, diagnosis, treatment, and our overall understanding of medicine continues to expand. This collection of in-depth ...
Collaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of Lumee™ wearable continuous tissue oxygen monitoring product ...
A panelist discusses how the injectable combination of cabotegravir and rilpivirine performed well in the real-world OPERA cohort, with over 95% of patients maintaining virologic suppression. However, ...
To apply for Clinical Practice, you must complete the following: Submit your application one semester prior to the Clinical Practice Semester. The application period will be the first three weeks of ...
How to Keep Up With Molecular Testing and Targeted Therapies in Lung Cancer Over the next few years, the analysis of circulating tumor DNA (ctDNA) through liquid biopsy is expected to enter clinical ...
Accelerating platform-driven clinical innovation across vascular, neurovascular, and cardiovascular applications through a centralized Bionanomatrix IP and R&D engine. BIRMINGHAM, AL / ACCESS Newswire ...
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results